Tilray Brands revenue rises 20% in Q1 2027

Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.

Tilray (TLRY) reported Q1 2027 revenue of $257 million, up 23% YoY, with expanded gross margins. The company highlighted its global scale, leadership in cannabis, beverage, and wellness, and strategic acquisitions like BrewDog. Tilray emphasized its diversified business model, international growth, and cost reductions in key markets like Portugal and Germany.

Tilray Brands Inc (TLRY) reported a Q1 net loss of $40M, down from a $1.5M profit last year, due to higher marketing costs and fuel surcharges. Revenue was impacted by cannabis price compression, supply constraints, and inventory shifts. BrewDog turned profitable, and the company expects continued growth. Tilray also discussed partnerships, international expansion, and potential M&A opportunities.

Tilray Brands reported Q1 2027 revenue of $257.1M, up 23% YoY, but a net loss of $43.1M and EPS of $(0.32). Growth was driven by beverage expansion and EMEA strength, while cannabis revenue declined 13%. The company attributed changes to the BrewDog acquisition and strategic shifts.

Tilray Brands reported a net loss of $40.0 million for Q2 2026, despite revenue growth to $257.1 million. Gross profit rose to $77.5 million, but operating loss was $24.1 million. Cannabis revenue declined, while beverage revenue increased. The company issued shares to repay debt and amended credit agreements to ease covenant testing.

Tilray reaffirmed its FY2027 adjusted EBITDA guidance of $68M-$75M. CEO Irwin Simon highlighted the company's focus on growth and long-term shareholder value. Tilray is integrating BrewDog and preparing for a deal with Carlsberg.